Carregant...
Non-Myeloablative Conditioning for Second Hematopoietic Cell Transplantation for Graft Failure in Patients with Non-Malignant Disorders: A prospective study and review of the literature
Allogeneic hematopoietic cell transplantation (HCT) effectively treats seeveral non-malignant disorders (NMD) such as selected lysosomal disorders, cerebral adrenoleukodystrophy, and hemoglobinopathies. However, rates of graft failure (GF) in non-malignant populations exceed those of patients with m...
Guardat en:
| Publicat a: | Bone Marrow Transplant |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5604220/ https://ncbi.nlm.nih.gov/pubmed/28092353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.356 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|